248 related articles for article (PubMed ID: 35543102)
1. Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial.
Rusman T; van der Weijden M; Nurmohamed MT; van Denderen CJ; Landewé R; Bet PM; Bijl CV; van der Laken CJ; van der Horst-Bruinsma IE
Scand J Rheumatol; 2023 Mar; 52(2):137-141. PubMed ID: 35543102
[TBL] [Abstract][Full Text] [Related]
2. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
3. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ankylosing spondylitis and non-radiographic axial spondyloarthritis in a multi-ethnic Asian population of Singapore.
Hong C; Kwan YH; Leung YY; Lui NL; Fong W
Int J Rheum Dis; 2019 Aug; 22(8):1506-1511. PubMed ID: 31090201
[TBL] [Abstract][Full Text] [Related]
5. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
[TBL] [Abstract][Full Text] [Related]
6. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
7. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
8. Which Metrological Index, the BASMI or EDASMI, is Best Correlated with Disease-Related Parameters in Spondylarthritis Patients?
Maatallah K; Triki W; Ferjani H; Nessib DB; Kaffel D; Hamdi W
Curr Rheumatol Rev; 2022; 18(3):224-229. PubMed ID: 35232353
[TBL] [Abstract][Full Text] [Related]
9. Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO.
Llop M; Moreno M; Navarro-Compán V; Juanola X; de Miguel E; Almodóvar R; Quintana EC; Sanz JS; Beltrán E; Montesinos MDR; Calvet J; Berenguer-Llergo A; Gratacós J;
Arthritis Res Ther; 2022 Jan; 24(1):30. PubMed ID: 35063018
[TBL] [Abstract][Full Text] [Related]
10. Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis.
Braun J; Blanco R; Marzo-Ortega H; Gensler LS; Van den Bosch F; Hall S; Kameda H; Poddubnyy D; van de Sande M; van der Heijde D; Zhuang T; Stefanska A; Readie A; Richards HB; Deodhar A
Arthritis Res Ther; 2023 May; 25(1):80. PubMed ID: 37194094
[TBL] [Abstract][Full Text] [Related]
11. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
12. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
Song IH; Weiß A; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Lange E; Freundlich B; Rudwaleit M; Sieper J
Ann Rheum Dis; 2013 Jun; 72(6):823-5. PubMed ID: 23172749
[TBL] [Abstract][Full Text] [Related]
13. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the clinical characteristics and quality of life of male and female patients with non-radiographic axial spondyloarthritis.
Unal Enginar A
Int Immunopharmacol; 2023 Oct; 123():110627. PubMed ID: 37494835
[TBL] [Abstract][Full Text] [Related]
15. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
16. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
[TBL] [Abstract][Full Text] [Related]
17. Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.
Dougados M; van der Heijde D; Sieper J; Braun J; Citera G; Lenaerts J; van den Bosch F; Wei JC; Pedersen R; Bonin R; Jones H; Marshall L; Logeart I; Vlahos B; Bukowski JF; Maksymowych WP
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1590-1598. PubMed ID: 28482137
[TBL] [Abstract][Full Text] [Related]
18. Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.
van der Heijde D; Baraliakos X; Hermann KA; Landewé RBM; Machado PM; Maksymowych WP; Davies OR; de Peyrecave N; Hoepken B; Bauer L; Nurminen T; Braun J
Ann Rheum Dis; 2018 May; 77(5):699-705. PubMed ID: 29343510
[TBL] [Abstract][Full Text] [Related]
19. Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankylosing Spondylitis Functional Index.
Hallström M; Klingberg E; Deminger A; Rehnman JB; Geijer M; Forsblad-d'Elia H
Arthritis Res Ther; 2023 Sep; 25(1):182. PubMed ID: 37749599
[TBL] [Abstract][Full Text] [Related]
20. Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial.
Proft F; Weiß A; Torgutalp M; Protopopov M; Rodriguez VR; Haibel H; Behmer O; Sieper J; Poddubnyy D
Ther Adv Musculoskelet Dis; 2021; 13():1759720X20987700. PubMed ID: 33796155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
